(Total Views: 304)
Posted On: 12/11/2019 12:55:42 PM
Post# of 62

$MGNX News Article - MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium https://marketwirenews.com/news-releases/macr...55945.html


My Twitter: WhyteStocks